首页> 外文会议>2011 International Conference on Remote Sensing, Environment and Transportation Engineering >Preparation, characterization and biodistribution of 10-hydroxycamptothecin loaded PEG-PHDCA nanoparticles
【24h】

Preparation, characterization and biodistribution of 10-hydroxycamptothecin loaded PEG-PHDCA nanoparticles

机译:负载10-羟基喜树碱的PEG-PHDCA纳米粒子的制备,表征和生物分布

获取原文

摘要

10-Hydroxycamptothecin (HCPT) is a promising anticancer agent against a broad spectrum of cancers. The clinical utilization is greatly limited by its instability and poor solubility in both water and organic solvents. In this paper, we synthesized poly (PEG cyanoacrylate-co-hexadecyl cyanoacrylate) PEG-PHDCA and prepared HCPT-loaded PEG-PHDCA nanoparticles by film-dispersion and hydration-sonication method. The result showed that the prepared nanoparticles demonstrated good stability and encapsulation efficiency was more than 80%, the average size was 141.6 ± 6.7 nm, the Zeta potential was −18.2 ± 2.2 mV and drug loading content was 2.92 ± 0.21%. In vitro drug release and in vivo pharmacokinetics of HCPT nanoparticles were compared with those of HCPT. The results demonstrated that the nanoparticles remarkably prolonged in vitro the release time and in vivo half life respectively. All studies in this paper demonstrated that PEG-PHDCA nanoparticles seem to be a appropriate delivery system for HCPT.
机译:10-羟基喜树碱(HCPT)是一种有前途的抗癌药物,可抗多种癌症。其不稳定性以及在水和有机溶剂中的溶解性差,极大地限制了临床利用。本文合成了聚(聚氰基丙烯酸酯-共聚氰基丙烯酸十六烷基酯)PEG-PHDCA,并通过薄膜分散和水合超声处理的方法制备了负载HCPT的PEG-PHDCA纳米颗粒。结果表明,制备的纳米颗粒具有良好的稳定性,包封率大于80%,平均粒径为141.6±6.7 nm,Zeta电位为-18.2±2.2 mV,载药量为2.92±0.21%。将HCPT纳米粒子的体外药物释放和体内药代动力学与HCPT进行了比较。结果表明,纳米粒子分别显着延长了体外释放时间和体内半衰期。本文所有研究均表明,PEG-PHDCA纳米颗粒似乎是HCPT的合适递送系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号